biotech · Coronary Artery Disease
Medtronic Trading NL
Medtronic BioPharma B.V.
Medtronic BioPharma is a biotech organization headquartered in EU. Primary therapeutic focus areas include Coronary Artery Disease. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to
NL HQ
9 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- NL
- Employees
- 9
- Programs
- 1
- Drugs
- 0
- Patents
- 0
Coronary Artery Stenting
Phase 2 · other · Coronary Artery Disease
Coronary Artery Stenting for Coronary Artery Disease is a Phase 2 program (other) at Medtronic BioPharma B.V. with 1 ClinicalTrials.gov record(s).
Internal code IP069
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Medtronic BioPharma B.V.
- Phase
- Phase 2
- Modality
- other
- Indication
- Coronary Artery Disease
- Status
- completed
- Trials
- 1